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Several authors evaluated the role of FDG-positron emission tomography (PET) in BCs reporting conflicting results on the detection rate (range 14-90%), as detailed in a recent systematic review. [1] A correct pathological identification of such tumors during the pre-operative setting is a key element for planning the best strategy of care, considering the different biological behavior of BCs. In fact, atypical carcinoids (ACs) are associated with a definitely poorer prognosis compared to typical carcinoids (TCs). [2] In this setting, Tatci et al. [3] have recently reported the FDG-PET/computed tomography (CT) findings in a cohort of 22 surgically treated BCs. The overall sensitivity of FDG-PET/CT for detecting BC was sub-optimal (81.8%) and sensitivity for lymph nodal metastases was poor (25%). Moreover, according to Tatci, [3] the radiometabolic evaluation "…cannot discriminate typical carcinoids from atypical ones and the absence of an FDG avid lesion cannot exclude pulmonary carcinoid tumor."
We have appreciated the contribution of the Authors in this controversial and still open debate that prompted us a series of reflections, discussed herein.
First of all, as recently remarked by Stefani, [4] considering the indolent biological behavior of such neoplasms (low mitotic count) an increased detection rate of FDG-PET could be
